Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-17-002102
Filing Date
2017-05-01
Accepted
2017-05-01 16:28:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 HIGHBRIDGE CAPITAL MANAGEMENT LLC p17-1043sc13g.htm SC 13G 57683
  Complete submission text file 0000902664-17-002102.txt   59703
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43381 | Film No.: 17801122
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G